(Q34627677)

3 August 2017

title

Heteroclitic serological response in esophageal and prostate cancer patients after NY-ESO-1 protein vaccination (English)

1 reference

3 August 2017

1 reference

4

Sacha Gnjatic

1 reference

3 August 2017

6

Achim A Jungbluth

1 reference

3 August 2017

16

Gerd Ritter

1 reference

3 August 2017

20

Lloyd J Old

1 reference

3 August 2017

13

Erika Ritter

1 reference

3 August 2017

5

Hiroyoshi Nishikawa

1 reference

3 August 2017

8

Akiko Uenaka

1 reference

3 August 2017

2

Hisashi Wada

1 reference

3 August 2017

3

Midori Isobe

1 reference

3 August 2017

12

Takashi Saika

1 reference

3 August 2017

15

Hiroshi Miyata

1 reference

3 August 2017

18

Ralph Venhaus

1 reference

3 August 2017

19

Linda Pan

1 reference

3 August 2017

Junji Kawada

1

1 reference

3 August 2017

Nami Okazaki

7

1 reference

3 August 2017

Yurika Nakamura

9

1 reference

3 August 2017

Shinichi Fujiwara

10

1 reference

3 August 2017

Naoaki Mizuno

11

1 reference

3 August 2017

Makoto Yamasaki

14

1 reference

3 August 2017

Roger Murphy

17

1 reference

3 August 2017

Yuichiro Doki

21

1 reference

3 August 2017

Eiichi Nakayama

22

1 reference

3 August 2017

language of work or name

English

0 references

publication date

25 May 2011

1 reference

International Journal of Cancer

3 August 2017

published in

1 reference

3 August 2017

volume

130

1 reference

3 August 2017

issue

3

1 reference

3 August 2017

page(s)

584-592

1 reference

A testicular antigen aberrantly expressed in human cancers detected by autologous antibody screening

3 August 2017

cites work

1 reference

NY-ESO-1: review of an immunogenic tumor antigen

21 January 2018

1 reference

A survey of the humoral immune response of cancer patients to a panel of human tumor antigens

21 January 2018

1 reference

NY-ESO-1 expression and immunogenicity in malignant and benign breast tumors

21 January 2018

1 reference

NY-ESO-1 expression and immunogenicity in esophageal cancer.

21 January 2018

1 reference

Induction of primary NY-ESO-1 immunity: CD8+ T lymphocyte and antibody responses in peptide-vaccinated patients with NY-ESO-1+ cancers.

21 January 2018

1 reference

CD8(+) T cell responses against a dominant cryptic HLA-A2 epitope after NY-ESO-1 peptide immunization of cancer patients

21 January 2018

1 reference

Recombinant NY-ESO-1 protein with ISCOMATRIX adjuvant induces broad integrated antibody and CD4+ and CD8+ T cell responses in humans

21 January 2018

1 reference

Vaccination with NY-ESO-1 protein and CpG in Montanide induces integrated antibody/Th1 responses and CD8 T cells through cross-priming.

21 January 2018

1 reference

Recombinant vaccinia/fowlpox NY-ESO-1 vaccines induce both humoral and cellular NY-ESO-1-specific immune responses in cancer patients.

21 January 2018

1 reference

High frequency of antitumor T cells in the blood of melanoma patients before and after vaccination with tumor antigens

21 January 2018

1 reference

Contrasting frequencies of antitumor and anti-vaccine T cells in metastases of a melanoma patient vaccinated with a MAGE tumor antigen

21 January 2018

1 reference

Adenovirus MART-1-engineered autologous dendritic cell vaccine for metastatic melanoma

21 January 2018

1 reference

A comparison of two types of dendritic cell as adjuvants for the induction of melanoma-specific T-cell responses in humans following intranodal injection.

21 January 2018

1 reference

Spreading of T-cell autoimmunity to cryptic determinants of an autoantigen

21 January 2018

1 reference

Epitope spreading in immune-mediated diseases: implications for immunotherapy

21 January 2018

1 reference

Recombinant NY-ESO-1 cancer antigen: production and purification under cGMP conditions.

21 January 2018

1 reference

Cancer/testis (CT) antigens: potential targets for immunotherapy

21 January 2018

1 reference

Seromic profiling of ovarian and pancreatic cancer

21 January 2018

1 reference

Identification of a unique antigen peptide pRL1 on BALB/c RL male 1 leukemia recognized by cytotoxic T lymphocytes and its relation to the Akt oncogene

21 January 2018

1 reference

Identification of CCDC62-2 as a novel cancer/testis antigen and its immunogenicity

21 January 2018

1 reference

In vivo antigen delivery by a Salmonella typhimurium type III secretion system for therapeutic cancer vaccines.

21 January 2018

1 reference

Immunization of malignant melanoma patients with full-length NY-ESO-1 protein using TLR7 agonist imiquimod as vaccine adjuvant

21 January 2018

1 reference

Concurrent trastuzumab and HER2/neu-specific vaccination in patients with metastatic breast cancer

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/IJC.26074

1 reference

3 August 2017

1 reference